Maria Lockhart, MD
Obstetrics & Gynecology · West Islip, NYNPI 1801908249
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 33.7% of the total. Reporting peaked in 2019 at $583 and has fallen 88.9% since, to $65 in 2025.
Across 45 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$312
- Hologic Sales And Service, LLC$127
- Exeltis, USA Inc.$77
- Astellas Pharma US Inc$71
- Daiichi Sankyo Inc.$61
- Pfizer$48
- plus $228 from 12 others
What the payments were for
- Food & beverage$88896%
- Education$354%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $312 |
| Hologic Sales And Service, LLC | 4 | $127 |
| Exeltis, USA Inc. | 5 | $77 |
| Astellas Pharma US Inc | 4 | $71 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Pfizer | 2 | $48 |
| Therapeuticsmd, Inc. | 2 | $36 |
| Mayne Pharma Commercial LLC | 1 | $29 |
| Lupin Inc. | 1 | $21 |
| Biogen | 1 | $19 |
| Duchesnay USA Incorporated | 1 | $19 |
| Organon | 3 | $18 |
| Mission Pharmacal Company | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
| Amgen | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$119
How this compares
$923 in reported general payments places this provider in the 65th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $1,255 |
| Ibandronate Sodium | 37 | $939 |
| Metronidazole | 19 | $510 |
| ValacyclovirValacyclovir Hcl | 18 | $414 |
| Nystatin | 44 | $408 |
| Terconazole | 11 | $336 |
| Alendronate Sodium | 37 | $324 |
| Triamcinolone Acetonide | 39 | $268 |
| Fluconazole | 17 | $179 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in West Islip
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.